UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome

International journal of molecular sciences, 2016-03, Vol.17 (3), p.367-367

2016

Volltextzugriff (PDF)

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Nutrition, metabolism, and cardiovascular diseases, 2020-07, Vol.30 (8), p.1236-1248

2020

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease in Children

Seminars in liver disease, 2018-02, Vol.38 (1), p.1-13

2018

Volltextzugriff (PDF)

Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review

The lancet. Gastroenterology & hepatology, 2022-04, Vol.7 (4), p.367-378

2022

Volltextzugriff (PDF)

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

PloS one, 2016-12, Vol.11 (12), p.e0168216-e0168216

2016

Volltextzugriff (PDF)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Annals of hepatology, 2024-01, Vol.29 (1), p.101133-101133, Article 101133

2024

Volltextzugriff (PDF)

Resolution of Fatty Liver and Risk of Incident Diabetes

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.3637-3643

2013

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

PloS one, 2013-02, Vol.8 (2), p.e57183-e57183

2013

Volltextzugriff (PDF)

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

Journal of hepatology, 2017-05, Vol.66 (5), p.1031-1036

2017

Volltextzugriff (PDF)

MAFLD and risk of CKD

Metabolism, clinical and experimental, 2021-02, Vol.115, p.154433-154433, Article 154433

2021

Volltextzugriff (PDF)

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes

Diabetes care, 2012-04, Vol.35 (4), p.717-722

2012

Volltextzugriff (PDF)

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring

BMC genomics, 2009-10, Vol.10 (1), p.478-478

2009

Volltextzugriff (PDF)

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study

PloS one, 2019-01, Vol.14 (1), p.e0208736-e0208736

2019

Volltextzugriff (PDF)

NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.1755-1765

2022

Volltextzugriff (PDF)

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME study

Hepatology (Baltimore, Md.), 2014-10, Vol.60 (4), p.1211-1221

2014

Volltextzugriff (PDF)

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Journal of hepatology, 2014-05, Vol.60 (5), p.1040-1045

2014

Volltextzugriff (PDF)

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Journal of hepatology, 2016-10, Vol.65 (4), p.791-797

2016

Volltextzugriff (PDF)

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2016, Vol.150 (1), p.7-10

2016

Volltextzugriff (PDF)

Association of metabolic dysfunction-associated fatty liver disease with kidney disease

Nature reviews. Nephrology, 2022-04, Vol.18 (4), p.259-268

2022

Volltextzugriff (PDF)

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.1597-1610.e7

2020

Volltextzugriff (PDF)

Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2659-2668

2023

Volltextzugriff (PDF)

Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study

Diabetes, obesity & metabolism, 2024-05, Vol.26 (5), p.1644-1657

2024

Volltextzugriff (PDF)

Maternal high‐fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1796-1808

2009

Volltextzugriff (PDF)

Redefining the golden hour for severe head injury in an urban setting: The effect of prehospital arrival times on patient outcomes

Injury, 2013-05, Vol.44 (5), p.606-610

2013

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes

Diabetes care, 2014-06, Vol.37 (6), p.1729-1736

2014

Volltextzugriff (PDF)

1 – 25 von 341

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(287)

Publikationsform

Artikel
(341)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Nonalcoholic Fatty Liver Disease in Children

Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Resolution of Fatty Liver and Risk of Incident Diabetes

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

MAFLD and risk of CKD

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study

NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME study

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease

Association of metabolic dysfunction-associated fatty liver disease with kidney disease

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)

Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study

Maternal high‐fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression

Redefining the golden hour for severe head injury in an urban setting: The effect of prehospital arrival times on patient outcomes

Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes

Aktive Filter

Suchergebnisse filtern